pharma consulting

pharma-consultant
Reliable Experts in Pharmacology Market: Pharma Consultants

In the new fast-paced world, with unlimited access to information and technology, it gets overwhelming for various companies, be it an established goliath or a new start-up, to take important deci...


Pharma news fro GSK, InCarda, BridgeBio
GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; B...

GSK eyes robust immune response from RSV vaccine  Cold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear...


Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; Abbott's MitraClip4; Grail Buyback
Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 ...

Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca  Samsung Biologics announced the conclusion of a long-term supply deal with AstraZeneca worth USD 330.8 Million. ...


Pharma News
Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than decade old Life Sciences-based investment firm special...


pharma news
Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay USD 20 for each share in cash for a total amount of US...


Pharma News
EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achill...

EicOsis has received USD 15Million grant from the National Institute of Drug Abuse (NIDA) to fund the clinical trials of non-opioid pain therapy. NIDA, with an aim to supplement NIH’s initiati...


Pharma News
EU approval for Imbruvica; Pharming licenses orphan drug

EU recommends the use of Imbruvica for two new indications The Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission (EC). Ibrutinib i...


transthyretin amyloidosis
Notizia

Arming antibiotics with a vaccination-like immune response Harnessing the ability of the body’s immune system has already well-tried to be effective in treating cancer. Marcos Pires, Ph.D., a Le...



Default Blog Image
NF-κB Inhibitors- A Promising Future

NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a protein transcription factor that can orchestrate complex biological processes such as cell survival, cytokine production...


Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...

ASCO Conference 2022
ASCO Conference 2022

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.